US 12,198,840

Application 17/600,102 · Granted Jan 14, 2025

Rare earth permanent magnet material and raw material composition,preparation method therefor and use thereof

Estimated expiration

June 13, 2041

14y 207d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTCN2020103430: Resource not found (404)
Earliest effective filing
Jul 22, 2020
+ 20 years
Jul 22, 2040
PTA +326d
Jun 13, 2041
No TD
—
Final
Jun 13, 2041

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
September 30, 2021
Earliest effective filing
July 22, 2020
Issue date
January 14, 2025
PTA
+326 days
Base expiry (before PTA)
July 22, 2040

July 22, 2020 + 20 years = July 22, 2040 + 326 PTA days = June 13, 2041

  • National stage entry of application PCTCN2020103430, filed Jul 22, 2020

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 17/600,102 · US 12,198,840

PatentReply compiles the prosecution history behind US 12,198,840: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12198840

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.